|
| |
 |
|
| LETTER TO EDITOR |
|
| Year : 2022 | Volume
: 16
| Issue : 2 | Page : 239 |
|
Novel coronavirus disease in kidney-transplant recipients: Correspondence
Pathum Sookaromdee1, Viroj Wiwanitkit2
1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. D.Y. Patil University, Pune, Maharashtra, India
| Date of Submission | 26-Nov-2021 |
| Date of Acceptance | 05-Apr-2022 |
| Date of Web Publication | 30-Jun-2022 |
Correspondence Address:
Dr. Pathum Sookaromdee
Private Academic Consultant, Bangkok
Thailand
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ijot.ijot_123_21
How to cite this article:
Sookaromdee P, Wiwanitkit V. Novel coronavirus disease in kidney-transplant recipients: Correspondence. Indian J Transplant 2022;16:239 |
Dear Editor,
We would like to share ideas on “Clinical characteristics and outcome of novel coronavirus disease in kidney transplant recipients: A single-center prospective observational study.”[1] Arumugam et al. concluded that “Our largest cohort of patients from India showed higher incidence of acute graft dysfunction and significant mortality in patients with COVID-19.”[1] This report can confirm problem of COVID-19 among transplant patients. An interesting observation is no association between background immunosuppression therapy and severity of disease. This might imply that the pathological process of COVID-19 in transplant case is mainly due to nonimmunological process. Regarding graft dysfunction, the cause is interesting. During COVID-19, there is significant rheological change,[2] and this might be an important factors leading to poor vascularization of graft and might related to graft rejection. Finally, mortality in COVID-19 case with underlying transplantation is an interesting issue for further studies. The present study gives some interesting observations, but there is no control; hence, the interpretation has to be careful. The mortality of COVID-19 depends on several factors including therapeutic management given to the patients. Further study with comparison to control group under the same therapeutic management might give more data on mortality in this issue.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Arumugam V, Sastry BV, Solomon DJ, Gopalakrishnan N, Kannan BS, Shankar P, et al. Clinical characteristics and outcome of novel coronavirus disease in kidney transplant recipients: A single-center prospective observational study. Indian J Transplant 2021;15:189-98.  [Full text] |
| 2. | Joob B, Wiwanitkit V. Blood viscosity of COVID-19 patient: A preliminary report. Am J Blood Res 2021;11:93-5. |
|
Search Pubmed for